4.4 Article

Prevalence of ECG testing and characteristics among new hydroxychloroquine and chloroquine users within a multi-center tertiary care center

Related references

Note: Only part of the references are listed.
Article Rheumatology

QTc interval prolongation in patients with systemic lupus erythematosus treated with hydroxychloroquine

Taihei Nishiyama et al.

Summary: The study aimed to investigate the impact of hydroxychloroquine treatment on corrected QT interval in patients with systemic lupus erythematosus and factors affecting QTc prolongation. The results indicated that HCQ treatment can lead to QTc prolongation, especially in patients with hypertension and longer SLE duration. However, multiple logistic regression analysis showed no significant differences among these factors in influencing QTc prolongation.

MODERN RHEUMATOLOGY (2021)

Article Rheumatology

American College of Rheumatology White Paper on Antimalarial Cardiac Toxicity

Julianna Desmarais et al.

Summary: Hydroxychloroquine and chloroquine, commonly used medications for various diseases, may pose cardiac toxicity risks, particularly in the experimental use for COVID-19, including the potential of QTc prolongation and TdP. Awareness and further research is needed to better understand the cardiovascular risk and safety profile of these therapies.

ARTHRITIS & RHEUMATOLOGY (2021)

Article Rheumatology

Hydroxychloroquine Blood Levels Predict Hydroxychloroquine Retinopathy

Michelle Petri et al.

ARTHRITIS & RHEUMATOLOGY (2020)

Review Rheumatology

Clinical and Structural Efficacy of Hydroxychloroquine in Rheumatoid Arthritis: A Systematic Review

Claire Rempenault et al.

ARTHRITIS CARE & RESEARCH (2020)

Article Medicine, General & Internal

Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19

A. B. Cavalcanti et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

QT interval parameters, anti-Ro antibody status, and disease activity in systemic lupus erythematosus

Mohamed Azharudeen et al.

JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH (2020)

Review Rheumatology

2019 update of the EULAR recommendations for the management of systemic lupus erythematosus

Antonis Fanouriakis et al.

ANNALS OF THE RHEUMATIC DISEASES (2019)

Review Public, Environmental & Occupational Health

Cardiac Complications Attributed to Chloroquine and Hydroxychloroquine: A Systematic Review of the Literature

Clotilde Chatre et al.

DRUG SAFETY (2018)

Review Rheumatology

Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review

G. Ruiz-Irastorza et al.

ANNALS OF THE RHEUMATIC DISEASES (2010)

Article Rheumatology

Protective Effect of Hydroxychloroquine on Renal Damage in Patients With Lupus Nephritis: LXV, Data From a Multiethnic US Cohort

Guillermo J. Pons-Estel et al.

ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)